Skip to content
10-K

Annual Report

Pelthos Therapeutics Inc. PTHS

0001919246-26-000013

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 11, 2026 3.36M sh
Shares Diluted FY 2025 · Dec 31, 2025 1.88M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 557.45K sh
Stock Repurchased FY 2025 · Dec 31, 2025 $0
Stock Repurchased FY 2025 · Dec 31, 2024 $75K
Capex FY 2025 · Dec 31, 2025 $99K
Capex FY 2025 · Dec 31, 2024 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 −$22.59M
Operating Cash Flow restated FY 2025 · Dec 31, 2024 −$5.79M
Cash And Equivalents FY 2025 · Dec 31, 2025 $17.97M
Cash And Equivalents FY 2025 · Dec 31, 2024 $513K
Stockholders Equity FY 2025 · Dec 31, 2025 $38.88M
Stockholders Equity restated FY 2025 · Dec 31, 2024 −$2.71M
Stockholders Equity restated FY 2025 · Dec 31, 2023 −$6.45M
Current Liabilities FY 2025 · Dec 31, 2025 $25.99M
Current Liabilities restated FY 2025 · Dec 31, 2024 $4.08M
Total Liabilities FY 2025 · Dec 31, 2025 $91.52M
Total Liabilities restated FY 2025 · Dec 31, 2024 $4.08M
Current Assets FY 2025 · Dec 31, 2025 $53.41M
Current Assets restated FY 2025 · Dec 31, 2024 $1.37M
Total Assets FY 2025 · Dec 31, 2025 $130.4M
Total Assets restated FY 2025 · Dec 31, 2024 $1.37M
Eps Diluted FY 2025 · Dec 31, 2025 −$23.04
Eps Diluted restated FY 2025 · Dec 31, 2024 −$14.27
Eps Basic FY 2025 · Dec 31, 2025 −$23.04
Eps Basic restated FY 2025 · Dec 31, 2024 −$14.27
Sga Expense FY 2025 · Dec 31, 2025 $42.45M
Sga Expense FY 2025 · Dec 31, 2024 $6.39M
Rd Expense FY 2025 · Dec 31, 2025 $1.23M
Rd Expense restated FY 2025 · Dec 31, 2024 $1.18M
Net Income FY 2025 · Dec 31, 2025 −$43.32M
Net Income restated FY 2025 · Dec 31, 2024 −$7.96M
Operating Income FY 2025 · Dec 31, 2025 −$32.43M
Operating Income restated FY 2025 · Dec 31, 2024 −$7.57M
Cost Of Revenue FY 2025 · Dec 31, 2025 $3.99M
Cost Of Revenue FY 2025 · Dec 31, 2024 $0
Revenue FY 2025 · Dec 31, 2025 $16.8M
Revenue FY 2025 · Dec 31, 2024 $0